Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network

Elena Signaroldi, Pasquale Laise, Silvia Cristofanon, Arianna Brancaccio, Elisa Reisoli, Sina Atashpaz, Maria Rosa Terreni, Claudio Doglioni, Giancarlo Pruneri, Paolo Malatesta, Giuseppe Testa

Research output: Contribution to journalArticle

Abstract

Malignant gliomas constitute one of the most significant areas of unmet medical need, owing to the invariable failure of surgical eradication and their marked molecular heterogeneity. Accumulating evidence has revealed a critical contribution by the Polycomb axis of epigenetic repression. However, a coherent understanding of the regulatory networks affected by Polycomb during gliomagenesis is still lacking. Here we integrate transcriptomic and epigenomic analyses to define Polycomb-dependent networks that promote gliomagenesis, validating them both in two independent mouse models and in a large cohort of human samples. We find that Polycomb dysregulation in gliomagenesis affects transcriptional networks associated with invasiveness and de-differentiation. The dissection of these networks uncovers Zfp423 as a critical Polycomb-dependent transcription factor whose silencing negatively impacts survival. The anti-gliomagenic activity of Zfp423 requires interaction with the SMAD proteins within the BMP signalling pathway, pointing to a novel synergic circuit through which Polycomb inhibits BMP signalling.

Original languageEnglish
Article number10753
JournalNature Communications
Volume7
DOIs
Publication statusPublished - Feb 29 2016

Fingerprint

Epigenetic Repression
Gene Regulatory Networks
Epigenomics
Glioma
Dissection
Transcription Factors
Survival
Proteins
dissection
Networks (circuits)
mice
proteins
interactions

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Signaroldi, E., Laise, P., Cristofanon, S., Brancaccio, A., Reisoli, E., Atashpaz, S., ... Testa, G. (2016). Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network. Nature Communications, 7, [10753]. https://doi.org/10.1038/ncomms10753

Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network. / Signaroldi, Elena; Laise, Pasquale; Cristofanon, Silvia; Brancaccio, Arianna; Reisoli, Elisa; Atashpaz, Sina; Terreni, Maria Rosa; Doglioni, Claudio; Pruneri, Giancarlo; Malatesta, Paolo; Testa, Giuseppe.

In: Nature Communications, Vol. 7, 10753, 29.02.2016.

Research output: Contribution to journalArticle

Signaroldi E, Laise P, Cristofanon S, Brancaccio A, Reisoli E, Atashpaz S et al. Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network. Nature Communications. 2016 Feb 29;7. 10753. https://doi.org/10.1038/ncomms10753
Signaroldi, Elena ; Laise, Pasquale ; Cristofanon, Silvia ; Brancaccio, Arianna ; Reisoli, Elisa ; Atashpaz, Sina ; Terreni, Maria Rosa ; Doglioni, Claudio ; Pruneri, Giancarlo ; Malatesta, Paolo ; Testa, Giuseppe. / Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network. In: Nature Communications. 2016 ; Vol. 7.
@article{2596e803431c4b439bc7249b1d10a6c9,
title = "Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network",
abstract = "Malignant gliomas constitute one of the most significant areas of unmet medical need, owing to the invariable failure of surgical eradication and their marked molecular heterogeneity. Accumulating evidence has revealed a critical contribution by the Polycomb axis of epigenetic repression. However, a coherent understanding of the regulatory networks affected by Polycomb during gliomagenesis is still lacking. Here we integrate transcriptomic and epigenomic analyses to define Polycomb-dependent networks that promote gliomagenesis, validating them both in two independent mouse models and in a large cohort of human samples. We find that Polycomb dysregulation in gliomagenesis affects transcriptional networks associated with invasiveness and de-differentiation. The dissection of these networks uncovers Zfp423 as a critical Polycomb-dependent transcription factor whose silencing negatively impacts survival. The anti-gliomagenic activity of Zfp423 requires interaction with the SMAD proteins within the BMP signalling pathway, pointing to a novel synergic circuit through which Polycomb inhibits BMP signalling.",
author = "Elena Signaroldi and Pasquale Laise and Silvia Cristofanon and Arianna Brancaccio and Elisa Reisoli and Sina Atashpaz and Terreni, {Maria Rosa} and Claudio Doglioni and Giancarlo Pruneri and Paolo Malatesta and Giuseppe Testa",
year = "2016",
month = "2",
day = "29",
doi = "10.1038/ncomms10753",
language = "English",
volume = "7",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network

AU - Signaroldi, Elena

AU - Laise, Pasquale

AU - Cristofanon, Silvia

AU - Brancaccio, Arianna

AU - Reisoli, Elisa

AU - Atashpaz, Sina

AU - Terreni, Maria Rosa

AU - Doglioni, Claudio

AU - Pruneri, Giancarlo

AU - Malatesta, Paolo

AU - Testa, Giuseppe

PY - 2016/2/29

Y1 - 2016/2/29

N2 - Malignant gliomas constitute one of the most significant areas of unmet medical need, owing to the invariable failure of surgical eradication and their marked molecular heterogeneity. Accumulating evidence has revealed a critical contribution by the Polycomb axis of epigenetic repression. However, a coherent understanding of the regulatory networks affected by Polycomb during gliomagenesis is still lacking. Here we integrate transcriptomic and epigenomic analyses to define Polycomb-dependent networks that promote gliomagenesis, validating them both in two independent mouse models and in a large cohort of human samples. We find that Polycomb dysregulation in gliomagenesis affects transcriptional networks associated with invasiveness and de-differentiation. The dissection of these networks uncovers Zfp423 as a critical Polycomb-dependent transcription factor whose silencing negatively impacts survival. The anti-gliomagenic activity of Zfp423 requires interaction with the SMAD proteins within the BMP signalling pathway, pointing to a novel synergic circuit through which Polycomb inhibits BMP signalling.

AB - Malignant gliomas constitute one of the most significant areas of unmet medical need, owing to the invariable failure of surgical eradication and their marked molecular heterogeneity. Accumulating evidence has revealed a critical contribution by the Polycomb axis of epigenetic repression. However, a coherent understanding of the regulatory networks affected by Polycomb during gliomagenesis is still lacking. Here we integrate transcriptomic and epigenomic analyses to define Polycomb-dependent networks that promote gliomagenesis, validating them both in two independent mouse models and in a large cohort of human samples. We find that Polycomb dysregulation in gliomagenesis affects transcriptional networks associated with invasiveness and de-differentiation. The dissection of these networks uncovers Zfp423 as a critical Polycomb-dependent transcription factor whose silencing negatively impacts survival. The anti-gliomagenic activity of Zfp423 requires interaction with the SMAD proteins within the BMP signalling pathway, pointing to a novel synergic circuit through which Polycomb inhibits BMP signalling.

UR - http://www.scopus.com/inward/record.url?scp=84959419702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959419702&partnerID=8YFLogxK

U2 - 10.1038/ncomms10753

DO - 10.1038/ncomms10753

M3 - Article

AN - SCOPUS:84959419702

VL - 7

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 10753

ER -